COYA
Coya Therapeutics, Inc. Common StockNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$106.26M
P/E Ratio
—
EPS
$-1.27
Beta
0.52
52W High
$7.75
52W Low
$3.71
50-Day MA
$4.60
200-Day MA
$5.61
Dividend Yield
—
Profit Margin
-267.10%
Forward P/E
—
PEG Ratio
—
About Coya Therapeutics, Inc. Common Stock
Coya Therapeutics, Inc., a clinical-stage biotechnology company, develops proprietary medicinal products to modulate the function of regulatory T cells (Tregs). The company is headquartered in Houston, Texas.
Fundamentals
| Revenue (TTM) | $7.95M |
| Gross Profit (TTM) | $-8.79M |
| EBITDA | $-20.24M |
| Operating Margin | -107.50% |
| Return on Equity | -51.40% |
| Return on Assets | -26.90% |
| Revenue/Share (TTM) | $0.47 |
| Book Value | $2.06 |
| Price-to-Book | 2.25 |
| Price-to-Sales (TTM) | 13.37 |
| EV/Revenue | 6.27 |
| EV/EBITDA | -6.21 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 202769.00% |
| Shares Outstanding | $23.46M |
| Float | $17.84M |
| % Insiders | 14.77% |
| % Institutions | 35.87% |
Historical Volatility
HV 10-Day
51.96%
HV 20-Day
44.07%
HV 30-Day
44.60%
HV 60-Day
58.40%
HV Rank
10.3%
Volatility is currently expanding
Analyst Ratings
Consensus ($15.64 target)
7
BuyData last updated: 4/10/2026